The United Kingdom aims to boost its life sciences profile as Aviva Capital Partners and Socius unveiled plans for a £1 billion ($1.3 billion) cancer research and manufacturing hub on the outskirts of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results